Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Healthtrust
Fuji
Teva
Cerilliant
Colorcon
Federal Trade Commission
US Department of Justice
McKinsey

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019057

« Back to Dashboard

NDA 019057 describes HYTRIN, which is a drug marketed by Abbott and is included in two NDAs. Additional details are available on the HYTRIN profile page.

The generic ingredient in HYTRIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
Summary for 019057
Tradename:HYTRIN
Applicant:Abbott
Ingredient:terazosin hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Aug 7, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 2MG BASE
Approval Date:Aug 7, 1987TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Aug 7, 1987TE:RLD:No

Expired US Patents for NDA 019057

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-002 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-002 Aug 7, 1987 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
US Department of Justice
Dow
Citi
QuintilesIMS
Johnson and Johnson
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot